RELX Technology Inc. announces 2024 unaudited financial report

Mar.14.2025
RELX Technology Inc. announces 2024 unaudited financial report
RELX Technology Inc. announced its unaudited financial report for Q4 2024, showing a 56.3% YoY revenue growth to 8.1 billion RMB.

On March 14, RELX Technology (RLX Technology Inc.) released its unaudited financial report for the fourth quarter and full year of 2024. The report shows that RELX Technology's net revenue for the fourth quarter of 2024 was 810 million yuan (110 million U.S. dollars), an increase of 7.6% compared to the previous quarter and a 56.3% increase year-on-year. Under non-GAAP, adjusted net profit for the fourth quarter was 250 million yuan (34.46 million U.S. dollars). The full year net revenue for 2024 was 2.75 billion yuan (380 million U.S. dollars), a 73.3% increase year-on-year. Under non-GAAP, adjusted net profit for the full year was 930 million yuan (130 million U.S. dollars).

 

 

Financial Summary for the Fourth Quarter of 2024 for RELX Technology 

 

 

In the fourth quarter of 2024, RELX Technology reported a net revenue of 810 million RMB (110 million USD), representing a 7.6% increase compared to the previous quarter and a 56.3% increase year-on-year. 

 

The year-on-year growth was mainly driven by the expansion of international business. The gross profit for the fourth quarter of 2024 was 220 million RMB (30.13 million USD), with a gross profit margin of 27.0%, representing a 3.3 percentage point increase compared to the same period last year. On a non-GAAP basis, the adjusted net profit for the fourth quarter of 2024 was 250 million RMB (34.46 million USD). 

 

As of December 31, 2024, RELX Technology had a total of 15.87 billion RMB (2.17 billion USD) in cash and cash equivalents, restricted cash, short-term bank deposits, short-term investments, long-term bank deposits, and long-term investment securities.

 

 

Financial Summary of 2024 

 

 

In 2024, net revenue amounted to 2.75 billion Chinese yuan (380 million US dollars), representing a year-on-year growth of 73.3%. 

 

The significant increase in revenue was mainly attributed to the expansion of international operations. Gross profit for the year was 730 million Chinese yuan (100 million US dollars), with a gross profit margin of 26.4%, a 2 percentage point increase compared to the previous year. 

 

On a non-US GAAP basis, adjusted net profit for the year was 930 million Chinese yuan (130 million US dollars). Research and development expenses for the 2024 fiscal year decreased by 48.9% to 88.3 million Chinese yuan (12.1 million US dollars) from the previous year's 172.7 million Chinese yuan, primarily due to lower equity incentive costs and reduced compensation and benefits.

 

RELX Technology founder, chairman, and CEO Ying Wang stated,

 

The year 2024 marked a milestone for RELX Technology, as the company made significant progress in global operations. We upgraded our organizational structure, optimized our business strategies to meet the increasingly diverse and dynamic needs of international markets, and launched several innovative products that were well-received globally. These efforts led to growth in performance and solidified our leading position in multiple global markets. Looking ahead to 2025, we will continue to focus on compliance in the market, concentrate on refining sales channels and diversifying product offerings to provide high-quality products for adult smokers. We will also actively respond to industry changes, seize new opportunities, and practice long-termism.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Opens Public Comment Period on Draft Guidance for Flavored E-Cigarette Applications
FDA Opens Public Comment Period on Draft Guidance for Flavored E-Cigarette Applications
The U.S. Food and Drug Administration’s Center for Tobacco Products announced an open public comment period for a draft guidance titled Flavored Electronic Nicotine Delivery Systems (ENDS) Premarket Applications – Considerations Related to Youth Risk.
Apr.09 by 2FIRSTS.ai
    Shenzhen Tobacco Monopoly Bureau Moves to Advance E-Cigarette Regulatory System 2.0
Shenzhen Tobacco Monopoly Bureau Moves to Advance E-Cigarette Regulatory System 2.0
The Shenzhen Tobacco Monopoly Bureau recently held the city’s 2026 e-cigarette regulation work conference to implement higher-level meeting requirements, review the city’s e-cigarette regulatory work in 2025 and during the 14th Five-Year Plan period, assess the current situation, and deploy the rollout of E-cigarette Regulatory System 2.0 across Shenzhen’s tobacco commercial system.
Apr.28 by 2FIRSTS.ai
Exclusive | China Starts Mandatory National Standards Process for Heated Cigarettes and Nicotine Pouches
Exclusive | China Starts Mandatory National Standards Process for Heated Cigarettes and Nicotine Pouches
China has launched mandatory national standards work for heated cigarettes and nicotine pouches, further formalizing regulation of both categories. The move may help lay groundwork for future market entry, but does not signal imminent domestic commercialization.
Apr.15
Nature Health Comment Urges Wider Role for Smoke-Free Nicotine Products in Tobacco Control
Nature Health Comment Urges Wider Role for Smoke-Free Nicotine Products in Tobacco Control
Ahead of World No Tobacco Day, a Nature Health Comment by Robert Beaglehole, Ruth Bonita and Tikki Pang argues that regulated smoke-free nicotine products could help accelerate the global decline in smoking. The authors propose a “smoke-free 2040” goal and call for risk-proportionate regulation distinguishing cigarettes from lower-risk nicotine alternatives.
News
May.20
WHO’s First Global Report on Nicotine Pouches: Harm Reduction Questions Remain Amid Global Regulatory Warning
WHO’s First Global Report on Nicotine Pouches: Harm Reduction Questions Remain Amid Global Regulatory Warning
Ahead of World No Tobacco Day 2026, WHO released its first global report on nicotine pouches, warning that rapid market growth, youth-oriented marketing and weak regulation are converging. 2Firsts views the report as an important warning, but not a complete risk assessment, with harm-reduction questions still unresolved.
Special Report
May.17
 Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
According to The Wall Street Journal, nicotine pouch brand Zyn has rapidly gained popularity across the Trump administration and conservative political circles, including among U.S. Health Secretary Robert F. Kennedy Jr.
Business
May.20